Patrick O'Brien's Insider Trades & SAST Disclosures
Patrick O'Brien's most recent trade in Merchants Bancorp was a trade of 536 Common Stock done at an average price of $32.7 . Disclosure was reported to the exchange on May 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Patrick O'Brien.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 32.71 per share. | 15 May 2025 | 536 | 117,861 (0%) | 0% | 32.7 | 17,533 | Common Stock |
| Greenlight Capital Re Ltd ... | Patrick O'Brien | Chief Operating Officer, SEE REMARKS | Sale of securities on an exchange or to another person at price $ 13.26 per share. | 12 May 2025 | 7,500 | 175,425 (0%) | 0% | 13.3 | 99,450 | ORDINARY SHARES |
| Greenlight Capital Re Ltd ... | Patrick O'Brien | Chief Operating Officer, SEE REMARKS | Sale of securities on an exchange or to another person at price $ 13.48 per share. | 12 May 2025 | 7,500 | 182,925 (0%) | 0% | 13.5 | 101,100 | ORDINARY SHARES |
| Greenlight Capital Re Ltd ... | Patrick O'Brien | Chief Operating Officer, SEE REMARKS | Sale of securities on an exchange or to another person at price $ 13.22 per share. | 12 May 2025 | 5,000 | 170,425 (0%) | 0% | 13.2 | 66,100 | ORDINARY SHARES |
| Greenlight Capital Re Ltd ... | Patrick O'Brien | Chief Operating Officer, SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 9,389 | 190,425 (0%) | 0% | 0 | ORDINARY SHARES | |
| Greenlight Capital Re Ltd ... | Patrick O'Brien | Chief Operating Officer, SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 29,277 | 181,036 (0%) | 0% | 0 | ORDINARY SHARES | |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 42.82 per share. | 20 Feb 2025 | 409 | 117,325 (0%) | 0% | 42.8 | 17,513 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2025 | 100,000 | 564,385 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 19.69 per share. | 04 Jan 2025 | 19,658 | 544,727 (0%) | 0% | 19.7 | 387,066 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 20.10 per share. | 04 Jan 2025 | 9,526 | 535,201 (0%) | 0% | 20.1 | 191,473 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 19.69 per share. | 04 Jan 2025 | 8,000 | 527,201 (0%) | 0% | 19.7 | 157,520 | Common Stock |
| Cineverse Corp - Ordinary ... | Patrick O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 24,433 | 128,493 (0%) | 0% | 0 | Class A Common Stock | |
| Merchants Bancorp | Patrick D. O'Brien | Director | Sale or transfer of securities back to the company at price $ 25.00 per share. | 02 Jan 2025 | 6,000 | 0 | - | 25 | 150,000 | Series B depositary shares |
| Merchants Bancorp | Patrick D. O'Brien | Director | Sale or transfer of securities back to the company at price $ 25.00 per share. | 02 Jan 2025 | 4,000 | 0 | - | 25 | 100,000 | Series B Depositary Shares |
| Merchants Bancorp | Patrick D. O'Brien | Director | Purchase of securities on an exchange or from another person at price $ 25.00 per share. | 18 Nov 2024 | 40,000 | 40,000 | - | 25 | 1,000,000 | Series E Depositary Shares |
| Merchants Bancorp | Patrick D. O'Brien | Director | Purchase of securities on an exchange or from another person at price $ 25.00 per share. | 18 Nov 2024 | 40,000 | 40,000 | - | 25 | 1,000,000 | Series E Depositary Shares |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 39.00 per share. | 18 Nov 2024 | 449 | 116,916 (0%) | 0% | 39 | 17,511 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 40.78 per share. | 15 Aug 2024 | 430 | 116,467 (0%) | 0% | 40.8 | 17,535 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Sale or transfer of securities back to the company at price $ 25.00 per share. | 01 Apr 2024 | 80,000 | 0 | - | 25 | 2,000,000 | Series A Preferred Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Sale or transfer of securities back to the company at price $ 25.00 per share. | 01 Apr 2024 | 23,000 | 0 | - | 25 | 575,000 | Series A Preferred Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 43.04 per share. | 01 Apr 2024 | 407 | 116,037 (0%) | 0% | 43.0 | 17,517 | Common Stock |
| Greenlight Capital Re Ltd ... | Patrick O'Brien | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 8,489 | 151,759 (0%) | 0% | 0 | ORDINARY SHARES | |
| Merchants Bancorp | O'Brien D. Patrick | Director | Grant, award, or other acquisition of securities at price $ 38.75 per share. | 14 Feb 2024 | 452 | 115,630 (0%) | 0% | 38.8 | 17,515 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 85,000 | 487,226 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 35.65 per share. | 03 Jan 2024 | 12,741 | 464,385 (0%) | 0% | 35.7 | 454,217 | Common Stock |
| Arrowhead Pharmaceuticals ... | O'Brien Patrick | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 34.99 per share. | 03 Jan 2024 | 8,200 | 477,126 (0%) | 0% | 35.0 | 286,918 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 31.83 per share. | 03 Jan 2024 | 3,849 | 408,726 (0%) | 0% | 31.8 | 122,514 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 32.52 per share. | 03 Jan 2024 | 2,800 | 405,926 (0%) | 0% | 32.5 | 91,056 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 33.99 per share. | 03 Jan 2024 | 1,900 | 485,326 (0%) | 0% | 34.0 | 64,581 | Common Stock |
| Arrowhead Pharmaceuticals ... | O'Brien Patrick | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 32.65 per share. | 03 Jan 2024 | 1,700 | 403,826 (0%) | 0% | 32.7 | 55,505 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 32.63 per share. | 03 Jan 2024 | 1,600 | 402,226 (0%) | 0% | 32.6 | 52,208 | Common Stock |
| Arrowhead Pharmaceuticals ... | O'Brien Patrick | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 33.41 per share. | 03 Jan 2024 | 400 | 405,526 (0%) | 0% | 33.4 | 13,364 | Common Stock |
| Cineverse Corp - Ordinary ... | O'Brien Patrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 80,372 | 104,060 (0%) | 0% | 0 | Class A Common Stock | |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 32.28 per share. | 15 Nov 2023 | 388 | 115,178 (0%) | 0% | 32.3 | 12,525 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 30.10 per share. | 17 Aug 2023 | 416 | 114,790 (0%) | 0% | 30.1 | 12,522 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Purchase of securities on an exchange or from another person at price $ 22.72 per share. | 13 Jun 2023 | 3,000 | 23,000 | - | 22.7 | 68,160 | Series A Preferred Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Purchase of securities on an exchange or from another person at price $ 21.32 per share. | 13 Jun 2023 | 1,500 | 6,000 | - | 21.3 | 31,980 | Series B depositary shares |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 23.80 per share. | 18 May 2023 | 526 | 114,374 (0%) | 0% | 23.8 | 12,519 | Common Stock |
| Greenlight Capital Re Ltd ... | Patrick O'Brien | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 9,413 | 143,270 (0%) | 0% | 0 | CLASS A ORDINARY SHARES | |
| Merchants Bancorp | Patrick D. O'Brien | Director | Purchase of securities on an exchange or from another person at price $ 23.25 per share. | 09 Mar 2023 | 3,999 | 4,500 | - | 23.3 | 92,977 | Series B depositary shares |
| Merchants Bancorp | Patrick D. O'Brien | Director | Purchase of securities on an exchange or from another person at price $ 23.25 per share. | 07 Mar 2023 | 500 | 500 | - | 23.3 | 11,625 | Series B depositary shares |
| Merchants Bancorp | Patrick D. O'Brien | Director | Purchase of securities on an exchange or from another person at price $ 23.00 per share. | 07 Mar 2023 | 1 | 501 | - | 23 | 23 | Series B depositary shares |
| Merchants Bancorp | Patrick D. O'Brien | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Feb 2023 | 80,000 | 40,000 | - | 0 | Series C Depositary Shares | |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 30.63 per share. | 16 Feb 2023 | 409 | 113,848 (0%) | 0% | 30.6 | 12,528 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 37.39 per share. | 05 Jan 2023 | 7,500 | 413,375 (0%) | 0% | 37.4 | 280,425 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 37.39 per share. | 05 Jan 2023 | 7,500 | 420,875 (0%) | 0% | 37.4 | 280,425 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 65,000 | 428,375 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 38.54 per share. | 03 Jan 2023 | 5,527 | 372,695 (0%) | 0% | 38.5 | 213,011 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 38.58 per share. | 03 Jan 2023 | 5,286 | 363,945 (0%) | 0% | 38.6 | 203,934 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 37.58 per share. | 03 Jan 2023 | 2,894 | 369,231 (0%) | 0% | 37.6 | 108,757 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 37.53 per share. | 03 Jan 2023 | 2,653 | 378,222 (0%) | 0% | 37.5 | 99,567 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 39.74 per share. | 03 Jan 2023 | 500 | 372,195 (0%) | 0% | 39.7 | 19,870 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 39.55 per share. | 03 Jan 2023 | 300 | 363,645 (0%) | 0% | 39.6 | 11,865 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 40.53 per share. | 03 Jan 2023 | 270 | 363,375 (0%) | 0% | 40.5 | 10,943 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 40.80 per share. | 03 Jan 2023 | 70 | 372,125 (0%) | 0% | 40.8 | 2,856 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.15 per share. | 21 Dec 2022 | 32,000 | 380,875 (0%) | 0% | 6.2 | 196,800 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2022 | 32,000 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Merchants Bancorp | Patrick D. O'Brien | Director | Purchase of securities on an exchange or from another person at price $ 21.00 per share. | 09 Dec 2022 | 3,700 | 43,700 | - | 21 | 77,700 | Series C Depositary Shares |
| Cineverse Corp - Ordinary ... | Patrick O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 171,006 | 473,752 (0%) | 0% | 0 | Class A Common Stock | |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 24.70 per share. | 16 Nov 2022 | 507 | 113,439 (0%) | 0% | 24.7 | 12,523 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Purchase of securities on an exchange or from another person at price $ 25.00 per share. | 22 Sep 2022 | 40,000 | 40,000 | - | 25 | 1,000,000 | Series D Depositary Shares |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 28.50 per share. | 18 Aug 2022 | 439 | 112,932 (0%) | 0% | 28.5 | 12,512 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 23.25 per share. | 19 May 2022 | 538 | 112,493 (0%) | 0% | 23.3 | 12,509 | Common Stock |
| Greenlight Capital Re Ltd ... | Patrick O'Brien | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 16,781 | 133,857 (0%) | 0% | 0 | CLASS A ORDINARY SHARES | |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 30.47 per share. | 17 Feb 2022 | 411 | 111,955 (0%) | 0% | 30.5 | 12,523 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 46.47 per share. | 17 Nov 2021 | 269 | 74,363 (0%) | 0% | 46.5 | 12,500 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 35.27 per share. | 19 Aug 2021 | 355 | 74,094 (0%) | 0% | 35.3 | 12,521 | Common Stock |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 42.95 per share. | 20 May 2021 | 292 | 73,739 (0%) | 0% | 42.9 | 12,541 | Common Stock |
| Cineverse Corp - Ordinary ... | Patrick O'Brien | Director | Sale of securities on an exchange or to another person at price $ 2.00 per share. | 25 Mar 2021 | 50,000 | 378,327 (0%) | 0% | 2.0 | 100,195 | Class A Common Stock |
| Cineverse Corp - Ordinary ... | Patrick O'Brien | Director | Sale of securities on an exchange or to another person at price $ 2.02 per share. | 25 Mar 2021 | 6,298 | 328,327 (0%) | 0% | 2.0 | 12,692 | Class A Common Stock |
| Greenlight Capital Re Ltd ... | Patrick O'Brien | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2021 | 30,501 | 117,076 (0%) | 0% | 0 | CLASS A ORDINARY SHARES | |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2021 | 90,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.22 per share. | 08 Feb 2021 | 90,000 | 383,375 (0%) | 0% | 5.2 | 469,800 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | General Counsel | Sale of securities on an exchange or to another person at price $ 88.88 per share. | 08 Feb 2021 | 45,348 | 298,811 (0%) | 0% | 88.9 | 4,030,530 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | General Counsel | Sale of securities on an exchange or to another person at price $ 88.08 per share. | 08 Feb 2021 | 31,255 | 344,159 (0%) | 0% | 88.1 | 2,752,940 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | General Counsel | Sale of securities on an exchange or to another person at price $ 86.72 per share. | 08 Feb 2021 | 7,961 | 375,414 (0%) | 0% | 86.7 | 690,378 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | General Counsel | Sale of securities on an exchange or to another person at price $ 89.66 per share. | 08 Feb 2021 | 5,436 | 293,375 (0%) | 0% | 89.7 | 487,392 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | General Counsel | Sale of securities on an exchange or to another person at price $ 72.67 per share. | 06 Jan 2021 | 13,243 | 293,375 (0%) | 0% | 72.7 | 962,369 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | General Counsel | Sale of securities on an exchange or to another person at price $ 72.27 per share. | 06 Jan 2021 | 10,615 | 306,618 (0%) | 0% | 72.3 | 767,146 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | General Counsel | Sale of securities on an exchange or to another person at price $ 70.78 per share. | 06 Jan 2021 | 1,142 | 317,233 (0%) | 0% | 70.8 | 80,831 | Common Stock |
| Arrowhead Pharmaceuticals ... | Patrick O'Brien | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2021 | 60,000 | 318,375 (0%) | 0% | 0 | Common Stock | |
| Merchants Bancorp | Patrick D. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 20.53 per share. | 15 Sep 2020 | 3,000 | 73,447 (0%) | 0% | 20.5 | 61,590 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges